Post-Market Observational Study of the WINX Sleep Therapy for the Treatment of Obstructive Sleep Apnea (OSA)

The UNMASK Study: A Post-Market Longitudinal Observational Study of the WinxTM Sleep Therapy System for the Treatment of Obstructive Sleep Apnea (OSA)

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01683721

Acronym

UNMASK

Enrollment

1000

Registered

2012-09-12

Start date

2012-09-30

Completion date

2014-02-28

Last updated

2013-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Brief summary

The objective of the Study is to observe the use and utility of the Winx Sleep Therapy System in a clinical practice, for the treatment of patients with obstructive sleep apnea (OSA).

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Exclusion criteria

* Has a severe respiratory disorder, such as severe lung disease, pneumothorax, etc. * Has loose teeth or advanced periodontal disease. * Is under the age of 18.

Countries

United States

Contacts

Primary ContactLawrence Siegel, MD

lsiegel@apnicure.com650-361-9399

Outcome results